Home | List of Topics | Heart and Circulatory System | Interventional Cardiology
Myocardial biopsy is a diagnostic procedure in which a small piece of heart muscle tissue is removed for examination.
Myocardial biopsy is performed in a procedure similar to (or during) cardiac catheterization. The skin is scrubbed and a local anesthetic is given. A thin tube (catheter) is inserted through a vein or artery, depending on whether cardiac tissue is needed from the right or left ventricle.
When myocardial biopsy is performed by itself, the catheter is most often inserted in the jugular vein in the neck and then carefully threaded into the heart. A type of moving x-ray images called fluoroscopy is used to guide the insertion. A catheter with jaws in its tip, called a bioptome, is then introduced. Once the bioptome is in place, three to five small pieces of tissue are removed from the heart muscle.
You will not be allowed to eat or drink for 6 - 8 hours before the test. The procedure takes place in the hospital. Generally, you will be admitted the morning of the procedure, but in some cases, you may need to be admitted the night before.
A health care provider will explain the procedure and its risks. You must sign a consent form.
The procedure will take place in a hospital radiology department, special procedures room, or cardiac diagnostics laboratory. You will be given a sedative prior to the procedure to help you relax, but you will remain awake and able to follow instructions during the test. You will lie flat on a stretcher or table for the duration of the test.
An incision will be made into a vein in your arm, neck, or groin for threading the catheter into your heart. You will be given a local anesthesia for the insertion of the catheter, and the only sensation you should feel will be pressure at the site. You may feel some discomfort due to lying still for a prolonged period of time.
The procedure may last from one to several hours.
This test is performed routinely after heart transplantation to watch for signs of rejection. It may also be performed when a disorder such as cardiomyopathy, myocarditis, or cardiac amyloidosis is suspected.
This test may reveal:
Additional conditions for which the test may be performed include:
Risks are moderate and include cardiac arrhythmias, trauma to the vein or artery, infection, blood clots (thrombosis) in the vein, bleeding from the biopsy site, pneumothorax, injury to the recurrent laryngeal nerve, and rupture of the heart (very rare).
Review Date:11/6/2006
Reviewed By:Glenn Gandelman, MD, MPH, Assistant Clinical Professor of Medicine, New York Medical College, Valhalla, NY. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.